Fluconazole and Rimifon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluconazole (fluconazole) and Rimifon (isoniazid). Common drug interactions include agranulocytosis among females and hepatitis fulminant among males.

The phase IV clinical study analyzes what interactions people have when they take Fluconazole and Rimifon. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Fluconazole?

Fluconazole has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 70,481 Fluconazole users. Check the latest studies of Fluconazole.

What is Rimifon?

Rimifon has active ingredients of isoniazid. eHealthMe is studying from 925 Rimifon users. Check the latest studies of Rimifon.



On Jul, 04, 2026

21 people who take Fluconazole and Rimifon together, and have interactions are studied.

Fluconazole and Rimifon drug interactions.

What are the common drug interactions of Fluconazole and Rimifon, by gender? *:

female:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  3. Pruritus (severe itching of the skin)
  4. Vomiting
  5. Erythema (redness of the skin)
  6. Liver disorder (liver diseases)
  7. Pyrexia (fever)
  8. Decreased appetite
  9. Haematemesis (vomiting of blood)
  10. Liver injury

male:

  1. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  2. Peripheral ischaemia (impaired circulation to an extremity)
  3. Central line infection (infection by central line in icu)
  4. Citrobacter infection (infection by citrobacter (bacteria))
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Cryptococcosis (potentially fatal fungal disease)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Hepatocellular damage (liver damage)
  9. Hiv infection
  10. Hyperbilirubinaemia (excess of bilirubin in the blood)

What are the common drug interactions of Fluconazole and Rimifon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  2. Prothrombin time ratio decreased

30-39:

n/a

40-49:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  3. Pruritus (severe itching of the skin)
  4. Vomiting
  5. Erythema (redness of the skin)
  6. Liver disorder (liver diseases)
  7. Peripheral ischaemia (impaired circulation to an extremity)
  8. Aortic thrombosis (formation of a blood clot inside aorta)
  9. Decreased appetite
  10. Haematemesis (vomiting of blood)

50-59:

  1. Anaemia (lack of blood)
  2. Anuria (failure of the kidneys to produce urine)
  3. Central line infection (infection by central line in icu)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  6. Lung infection
  7. Septic shock (shock due to blood infection)
  8. Serratia infection (bacterial infection)

60+:

  1. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Pain in limb
  4. Peripheral neuropathy (damage to nerves of the peripheral nervous system)
  5. Pyrexia (fever)
  6. Blood lactate dehydrogenase increased
  7. Cryptococcosis (potentially fatal fungal disease)
  8. Drug ineffective
  9. Hepatitis (inflammation of the liver)
  10. Hepatocellular damage (liver damage)

What are the existing conditions these people have? *

  1. Cryptococcosis (potentially fatal fungal disease): 8 people, 38.10%
  2. Hiv Infection: 7 people, 33.33%
  3. Disseminated Tuberculosis: 3 people, 14.29%
  4. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Fluconazole and Rimifon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fluconazole and Rimifon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fluconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rimifon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rimifon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fluconazole and isoniazid (the active ingredients of Fluconazole and Rimifon, respectively), and Fluconazole and Rimifon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: